Photo |
Details |
Speaker |
Organization |
Speech Title |
 |
Jan 09
2:30-3:30pm
PSC 124 |
Dr. Ivan Dmochowski |
University of Pennsylvania |
Xenon-129 MRI Contrast Agents for Molecular Imaging |
 |
Feb 13
2:30-3:30pm
PSC 124 |
Dr. Huamin Wang |
The University of Texas |
Exploring the functions of tumor microenvironment in tumorigenesis and prognosis of pancreatic cancer |
 |
Feb 27
2:30-3:30pm
PSC 124 |
Dr. Peter Caravan |
Harvard Medical School |
Development and Clinical Translation of Molecular MR and PET Imaging Probes |
 |
Feb 28
2:30-3:30pm
PSC 124 |
Dr. Yun (Nancy) Huang |
Texas A&M University; Health Science Center |
Deciphering the 6th base (5-hydroxymethylcytosine) in the cancer genome |
 |
Mar 13
2:30-3:30pm
PSC 124 |
Dr. Zuben Sauna |
U.S. Food and Drug Administration |
Immune system responses to therapeutic proteins: Getting up close and personal |
 |
Mar 20
2:30-3:30pm
PSC 124 |
Dr. Phillip Zhe Sun |
Emory University; Yerkes NPRC |
TBD |
 |
Mar 27
2:30-3:30pm
PSC 124 |
Dr. Neal Devaraj |
University of California |
TBD |
 |
Apr 10
2:30-3:30pm
PSC 124 |
Dr. Keith Wilkinson |
Emory University |
TBD |
 |
Apr 24
2:30-3:30pm
PSC 124 |
Dr. Michael Tweedle |
The Ohio State University |
TBD |
 |
May 29
2:30-3:30pm
PSC 124 |
Dr. Pradip Mascharak |
University of California |
Taming of the Shrew: Controlled Carbon Monoxide Delivery to Combat Malignancies |